cardiac resynchronisation therapy

R&D

Increasingly, electrophysiologists are exploring approaches that activate the heart through its intrinsic conduction pathways.

News

Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.